Research funded by the British Heart Foundation looking at tissue fibrosis (scarring), will soon be published in Experimental Gerontology, one the world’s leading journal on ageing. Fibrosis occurs naturally as part of our injury response process but also develops in ageing and chronic disease. Treatments are scant despite fibrosis leading to organ failure and increased risk of death.
The image shows valves (v) in the hearts of young and ‘late middle aged’ fruit flies that have been genetically engineered to express fluorescent collagen, an key ‘scar protein’. Although the fly heart is just two cells wide it represents a lot of the genetic machinery for a human heart. Amazingly, the function of human and fly hearts declines as they age – and they both accumulate collagen.
Our previous work linked heart function with SPARC – a protein associated with fibrosis in humans. We’ve now demonstrated that the heart’s ‘health-span’ during ageing can be significantly lengthened if the expression SPARC is reduced. We also show that if SPARC levels increase – fibrosis is increased too. Hence, we’ve nailed a cause-and-effect relationship between SPARC and heart function which supports the idea of targeting SPARC clinically to control cardiac health and fibrosis.
Paul S. Hartley (Department of Life and Environmental Science).
Social Work, Precarity & Sacrifice as Radical Action for Hope










3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
BU M.Res. student’s evidence to UK Parliamentary Women & Equalities Committee
Prof Marahatta promoting BU-Nepal collaboration
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease